MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceuticals_Inflammation, Allergy & Autoimmune
Merida Biosciences
Finance & Acquisition: Merida Biosciences
Parents
Merida Biosciences
Children
2025: Merida Biosciences Launches with $121M to Create Therapeutics for Multiple Autoimmune and Allergic Diseases
2025: The financing was co-led by Bain Capital Life Sciences, BVF Partners and Third Rock Ventures, joined by GV and Perceptive Xontogeny Venture Funds (PXV Funds).
2026: Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push_www.cnbc.com
Jumps
Key People: Merida Biosciences
Organization & Developments: Merida Biosciences